Prof. Bin Liang 梁斌
Chief Physician, Professor
Department of Interventional Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Interventional radiology for liver diseases, peripheral vascular conditions, neurointerventional treatments for ischemic lesions, and abdominal imaging diagnosis.
Dr. Liang is Chief Physician, Professor, and Deputy Director of Interventional Radiology at Union Hospital. Holding a medical doctorate, Dr. Liang was a visiting scholar at MD Anderson Cancer Center. Dr. Liang has led three National Natural Science Foundation projects, published 33 SCI papers, and received awards including the SIR & JVIR Outstanding Experimental Research Award.
Professional roles
- Member and Secretary, Interventional Radiology Group, Radiology Branch, Chinese Medical Association
- Member, Interventional Physicians Branch, Chinese Medical Doctor Association
- Member, Tumor Ablation Therapy Committee, China Anti-Cancer Association
- Vice Chair, Interventional Medicine Branch, Hubei Medical Association
Name order: in Chinese the family name comes first (Liang Bin). Papers usually list the name as Bin Liang or Liang B.
Selected publications
100 papers on PubMed matched by name and affiliation; 31 as first or senior author since 2016. Most recent first- or senior-author papers:
- MedComm (2020), 2026 (senior author): Neutrophil Extracellular Traps: From Mechanistic Insights to Therapeutic Targeting. PubMed 43011339
- Arch Bronconeumol, 2026 (senior author): One-stop Management of Massive Hemoptysis: Intraprocedural Angio-CT Guidance for Bronchial Artery Embolization. PubMed 41765698
- BMC Cancer, 2026 (senior author): FOLFOX-HAIC plus regorafenib for the treatment of unresectable colorectal liver metastases refractory to first and second-line systemic chemotherapy. PubMed 42458315
- Eur Radiol, 2026 (senior author): Clinical outcomes after TIPS: comparison of patients with a history of partial splenic embolization vs splenectomy in cirrhosis. PubMed 41565795
- Front Oncol, 2026 (senior author): Multimodal imaging techniques in Yttrium-90 radioembolization for hepatocellular carcinoma: a modality-oriented clinical review. PubMed 41710661
- Cancers (Basel), 2026 (senior author): Efficacy and Safety of HAIC Combined with PD-(L)1 Inhibitors and Bevacizumab Versus HAIC with PD-(L)1 Inhibitors and TKIs in Advanced Hepatocellular Carcinoma: A Retrospective Cohort Study. PubMed 41595233
- Int J Biol Macromol, 2026 (senior author): Hyaluronidase optimizes TACE in hepatocellular carcinoma by remodeling tumor stroma and enhancing chemotherapy penetration. PubMed 41443445
- BMC Gastroenterol, 2025 (senior author): Feasibility, efficacy, and safety of ventral caudal artery access for transarterial chemoembolization in a rat hepatocellular carcinoma model. PubMed 40596855
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that the papers match this doctor's specialty; this check is automatic.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion